Current Report Filing (8-k)
December 06 2019 - 5:28PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): December 6, 2019
CARDAX,
INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
333-181719
|
|
45-4484428
|
(State
or other jurisdiction
|
|
(Commission
|
|
(IRS
Employer
|
of
incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
2800
Woodlawn Drive, Suite 129, Honolulu, Hawaii 96822
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (808) 457-1400
Not
applicable
(Former
name or former address, if changed since last report)
Securities registered pursuant to Section
12(b) of the Act:
Title
of each class
|
|
Trading
Symbol
|
|
Name
of each exchange on which registered
|
Common
Stock, par value $0.001 per share
|
|
CDXI
|
|
OTCQB
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item
7.01 Regulation FD Disclosure
On
December 6, 2019, Cardax, Inc., a Delaware corporation (the “Company”), made available a corporation presentation,
which is attached hereto as Exhibit 99.1. A copy of this presentation has been made available on the Company’s corporate
website at www.cardaxpharma.com on the date of this report.
In
accordance with General Instruction B.2 of Form 8-K, the information set forth herein and in the presentation is deemed to be
“furnished” and shall not be deemed to be “filed” for purposes of the Exchange Act. The information set
forth in Item 7.01 of this Current Report on Form 8-K shall not be deemed an admission as to the materiality of any information
in this Current Report on Form 8-K that is required to be disclosed solely to satisfy the requirements of Regulation FD.
Forward-Looking
Statements
This
filing includes statements that are not historical facts. These “forward-looking statements” can be identified by
use of terminology such as “anticipate,” “believe,” “estimate,” “expect,” “hope,”
“intend,” “may,” “plan,” “positioned,” “project,” “propose,”
“should,” “strategy,” “will,” or any similar expressions. You should be aware that these forward-looking
statements are subject to risks and uncertainties that are beyond our control. Although we believe that our assumptions underlying
such forward-looking statements are reasonable, we do not guarantee our future performance, and our actual results may differ
materially from those contemplated by these forward-looking statements. Our assumptions used for the purposes of the forward-looking
statements specified in the following information represent estimates of future events and are subject to uncertainty as to possible
changes in economic, legislative, industry, and other circumstances, including the development, acceptance and sales of our products
and our ability to raise additional funding sufficient to implement our strategy. As a result, the identification and interpretation
of data and other information and their use in developing and selecting assumptions from and among reasonable alternatives require
the exercise of judgment. In light of these numerous risks and uncertainties, we cannot provide any assurance that the results
and events contemplated by our forward-looking statements will in fact transpire. These forward-looking statements are not guarantees
of future performance. You are cautioned to not place undue reliance on these forward-looking statements, which speak only as
of their dates. We do not undertake any obligation to update or revise any forward-looking statements.
Item
9.01. Financial Statements and Exhibits
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Dated:
December 6, 2019
|
CARDAX,
INC.
|
|
|
|
|
By:
|
/s/
David G. Watumull
|
|
|
David
G. Watumull
|
|
|
Chief
Executive Officer and President
|
Cardax (CE) (USOTC:CDXI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cardax (CE) (USOTC:CDXI)
Historical Stock Chart
From Apr 2023 to Apr 2024